Haiquan Chen

<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers

Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

<i>RET</i> Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer

Rui Wang, Haichuan Hu, Yunjian Pan et al. · Journal of Clinical Oncology · 2012 · 543 citations

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry

Wenhua Liang, Jiaxi He, Yaxing Shen et al. · Journal of Clinical Oncology · 2017 · 353 citations · Full text

Surgical Oncology, Epidemiology Of Cancer, Threshold Eln Count +18

Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases

Yihua Sun, Yan Ren, Zhaoyuan Fang et al. · Journal of Clinical Oncology · 2010 · 329 citations

Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial

Dongsheng Yue, Shidong Xu, Qun Wang et al. · The Lancet Respiratory Medicine · 2018 · 288 citations

Medicine, Pathology, Erlotinib Versus Vinorelbine +8